BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
Parents speak out as 4-year-old fights button battery injury in intensive care unit - 2'Wicked: For Good' was filmed at this surreal National Park in Egypt
- 3NAFFIC, AWARE claim first China-EU DPP for textiles
- 4Met Gala 2026 will celebrate fashion as an 'embodied art form': A guide to the theme, dress code, cochairs and hosting committee of the starry event
- 5Releasing Learning Experiences: A Survey of the \Learning Made Fun\ Instructive Application
- Polish law aimed at lowering petrol prices takes effect
- Weight-loss pill approval set to accelerate food industry product overhauls
- NASA's Perseverance Mars rover could break the record for miles driven on another planet
- Iran-backed Iraqi militias attack Kurdistan over 450 times since beginning of war
- Two Endangered Bengal Tiger Cubs Die Days Apart at Zoo After Contracting Virus
- Meet Beef the bulldog, who takes slow walks with his 78-year-old friend
- Influencers are selling a delusional fantasy of being postpartum. Why is it so easy to believe?
- Virtual reality opens doors for older people to build closer connections in real life
- Finding Ideal Date Spots for Two or three Encounters
